Terns Pharmaceuticals, Inc.

NASDAQ:TERN

8.955 (USD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -90.21-60.345-50.158-40.571-68.819-18.018
Depreciation & Amortization 0.8811.0320.5120.3940.1950.065
Deferred Income Tax 0.1410.3920.2190.6930.2060.307
Stock Based Compensation 25.53610.7688.1461.6910.6680.234
Change In Working Capital 1.291-1.037-1.4255.061.774-0.352
Accounts Receivables 000000
Inventory 000000
Accounts Payables 1.149-0.7221.727-1.1460.7220.488
Other Working Capital 0.142-0.315-3.1526.2061.052-0.84
Other Non Cash Items -5.3730.0810.8792.924-0.246-0.307
Operating Cash Flow -67.734-49.109-41.827-29.809-66.222-18.071
Investing Activities:
Investments In Property Plant And Equipment -0.052-0.275-0.34-0.584-0.9-0.244
Acquisitions Net 0.0380.0220.119-0.0070.00312.042
Purchases Of Investments -275.781-139.731-166.297-0.715-58.385-6.949
Sales Maturities Of Investments 237.846117.73446.9417.99255.4292.417
Other Investing Activites -0.038-0.022-0.1190.007-0.003-0.005
Investing Cash Flow -37.987-22.272-119.6966.693-3.856-4.776
Financing Activities:
Debt Repayment 00-12.88-16.876-0.058-0.058
Common Stock Issued 42.295167.496136.36269.3770.02687.661
Common Stock Repurchased 0.410.2430000
Dividends Paid 000000
Other Financing Activities -0.344-0.40110.91133.0140.09499.761
Financing Cash Flow 42.295167.496134.39385.5150.06299.761
Other Information:
Effect Of Forex Changes On Cash 0.117-0.178-0.0250.08-0.1310.103
Net Change In Cash -63.30995.536-27.15562.479-70.14777.017
Cash At End Of Period 79.926143.23547.69974.85412.37582.522